Welcome to join us for keynote panel
AI in Real-World Data analytics: capturing the value for drug development
Date: 3 November 2021
Time: 9:40 - 10:20 AM CET
- What are the biggest value drivers in using AI in RWD analyses?
- What are some of the considerations around AI IP protection?
- How can we as an industry capture the value of AI in drug development while adhering to global data privacy legislation?
- How do we overcome the barriers in accessing images for deploying AI for independently evaluating patient outcomes?
Panel
Jennifer Cubino
(Moderator)
COO, Customer Success & Data Science, BC Platforms
Iris Grossman
Chief Strategy Officer, Eleven Therapeutics
Tõnu Esko
Head of Estonian Biobank Innovation Center
Sanjoy Paul
Real World Evidence Leader – Oncology, AstraZencea
Maria Del Pilar Schneider
Senior Data Mining Statistician, IPSEN Innovation
